Corline Biomedical publishes interim report for Q1 2026
Net sales increased to 4,291 KSEK. The result after financial net was -2,501 KSEK. Issue and loan from Kardium provided 18.5 MSEK.
See the latest news and media coverage for Corline. We track all announcements, press releases, and industry mentions in real time, all in one place.
Antithrombotic and antiinflammatory surface coating solutions provider
corline.seLast updated
In short: Corline Biomedical expanded its presence in the U.S. market through a landmark 10-year agreement with Kardium and secured strategic funding.
Net sales increased to 4,291 KSEK. The result after financial net was -2,501 KSEK. Issue and loan from Kardium provided 18.5 MSEK.
The annual report for the accounting year 2025 is made available on the company's website www.corline.se.
The annual general meeting is held on 12 May 2026 in Uppsala with proposals regarding board election, fees and share issue authorization.
Net sales amounted to 7,651 KSEK. Result after financial items was -14,714 KSEK. Product CHS™ is used in commercial launch in the USA.
Corline Biomedical AB will release its next earnings report on Aug 21, 2026.
The Corline Biomedical AB EPS (TTM) is -0.57.
U.S. President Donald Trump is injecting nearly $9 billion into Intel in exchange for a 9.9% equity stake. But the money - which the struggling...
Asian stock markets fought to hold their footing on Tuesday after a furious flight from U.S. assets undermined Wall Street and the dollar, while concerns...
Track Corline and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.